UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review

Journal of gastroenterology and hepatology, 2013-01, Vol.28 (1), p.24-30

2013

Volltextzugriff (PDF)

Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease

PLoS genetics, 2017-03, Vol.13 (3), p.e1006641-e1006641

2017

Volltextzugriff (PDF)

Impact of colonoscopy bowel preparation on intestinal microbiota

PloS one, 2013-05, Vol.8 (5), p.e62815-e62815

2013

Volltextzugriff (PDF)

Comparative genomics and phenotypic studies to determine site-specificity of Escherichia coli in the lower gastrointestinal tract of humans

Gut microbes, 2023-12, Vol.15 (1), p.2223332-2223332

2023

Volltextzugriff (PDF)

A macrophage colony-stimulating factor receptor–green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse

Blood, 2003-02, Vol.101 (3), p.1155-1163

2003

Volltextzugriff (PDF)

Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia

Internal medicine journal, 2019-07, Vol.49 (7), p.859-866

2019

Volltextzugriff (PDF)

Escherichia coli diversity in the lower intestinal tract of humans

Environmental microbiology reports, 2015-08, Vol.7 (4), p.642-648

2015

Volltextzugriff (PDF)

Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes

JGH open, 2020-04, Vol.4 (2), p.166-171

2020

Volltextzugriff (PDF)

The microbiome of Crohn's disease aphthous ulcers

Gut pathogens, 2018-10, Vol.10 (1), p.44-44, Article 44

2018

Volltextzugriff (PDF)

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study

BMJ open, 2021-02, Vol.11 (2), p.e042493

2021

Volltextzugriff (PDF)

Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls

Frontiers in cellular and infection microbiology, 2018-09, Vol.8, p.336-336

2018

Volltextzugriff (PDF)

Vale Professor William Doe (6 May 1941–23 August 2022)

Journal of gastroenterology and hepatology, 2022-11, Vol.37 (11), p.2191-2192

2022

Volltextzugriff (PDF)

The role of inflammation in temporal shifts in the inflammatory bowel disease mucosal microbiome

Gut microbes, 2018-11, Vol.9 (6), p.477-485

2018

Volltextzugriff (PDF)

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1201-1214

2019

Volltextzugriff (PDF)

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2013-08, Vol.369 (8), p.699-710

2013

Volltextzugriff (PDF)

Detection of bacterial DNA in lymph nodes of Crohn's disease patients using high throughput sequencing

Gut, 2014-10, Vol.63 (10), p.1596-1606

2014

Volltextzugriff (PDF)

Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease

Journal of gastroenterology and hepatology, 2012-02, Vol.27 (2), p.193-194

2012

Volltextzugriff (PDF)

Comparative genomics of Crohn's disease-associated adherent-invasive Escherichia coli

Gut, 2017-08, Vol.66 (8), p.1382

2017

Volltextzugriff (PDF)

Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2007-06, Vol.132 (7), p.2313-2319

2007

Volltextzugriff (PDF)

Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa

Journal of leukocyte biology, 1996-06, Vol.59 (6), p.804-812

1996

Volltextzugriff (PDF)

The microbiome of translocated bacterial populations in patients with and without inflammatory bowel disease

Internal medicine journal, 2018-11, Vol.48 (11), p.1346-1354

2018

Volltextzugriff (PDF)

Quality of care in inflammatory bowel disease: actual health service experiences fall short of the standards

Internal medicine journal, 2020-10, Vol.50 (10), p.1216-1225

2020

Volltextzugriff (PDF)

The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease

Human genetics, 2024-03, Vol.143 (3), p.233-261

2024

Volltextzugriff (PDF)

Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report

World journal of clinical oncology, 2019-10, Vol.10 (10), p.350-357

2019

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(65)
Berichte
(2)

Sprache

Englisch
(67)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review

Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease

Impact of colonoscopy bowel preparation on intestinal microbiota

Comparative genomics and phenotypic studies to determine site-specificity of Escherichia coli in the lower gastrointestinal tract of humans

A macrophage colony-stimulating factor receptor–green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse

Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia

Escherichia coli diversity in the lower intestinal tract of humans

Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes

The microbiome of Crohn's disease aphthous ulcers

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study

Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls

Vale Professor William Doe (6 May 1941–23 August 2022)

Fine-Scale Structure Analysis Shows Epidemic Patterns of Clonal Complex 95, a Cosmopolitan Escherichia coli Lineage Responsible for Extraintestinal Infection

The role of inflammation in temporal shifts in the inflammatory bowel disease mucosal microbiome

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Detection of bacterial DNA in lymph nodes of Crohn's disease patients using high throughput sequencing

Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease

Comparative genomics of Crohn's disease-associated adherent-invasive Escherichia coli

Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa

The microbiome of translocated bacterial populations in patients with and without inflammatory bowel disease

Quality of care in inflammatory bowel disease: actual health service experiences fall short of the standards

The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease

Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report

Suchergebnisse filtern